Boston’s WaveWriter SCS systems gain expanded non-surgical back pain indication from US FDA
Boston Scientific Corporation announced today that the US Food and Drug Administration (FDA) has approved an expanded indication of the company’s WaveWriter spinal cord...
Study indicates benefits of switching from microscope to 3D exoscope in spine surgery
Researchers and neurosurgeons at the Medical University of South Carolina (MUSC; Charleston, USA) retrospectively compared the operative microscope to the 3D exoscope in a...
Medtronic announces trial data on closed-loop and DTM SCS therapies at NANS 2024
At this year’s North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA), Medtronic announced new data from two clinical trials demonstrating...
Boston Scientific announces positive WaveWriter SCS findings from SOLIS trial
Boston Scientific Corporation has announced positive one-year results from the SOLIS randomised controlled trial, demonstrating sustained pain relief using its WaveWriter Alpha spinal cord...